Recovered plasma for fractionation: call for quality standards to end wastage.

Plasma-derived protein therapeutics include coagulation factors and immunoglobulins, which are on the WHO Model List of Essential Medicines [1]. If qualified, this currently wasted plasma could be used to manufacture safe and effective products to save or improve the quality of life of patients with haemophilia, primary immune deficiency, and many other congenital or acquired diseases associated with a treatable plasma protein deficiency [4]. [Extracted from the article]